By Professor Michael Proinsias Farrell

Conference Presentations

Foley C; Domberelli A; Seccull A; La Hera Fuentes G; Hedger D; Gill T; Jones P; Fox S; Collie P; Tyler V; Kerr N; Auld R; Bailey A; Stephens A; Stolk SS; Asare-Doku W; Izzard T; Doyle M; Farnbach S; Gates P; Farrell M, 2024, 'Greater than the sum of its parts: Establishing a base for collaborative research in regional NSW to improve drug and alcohol outcomes in rural, regional, and remote communities', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024

Weatherburn D; Rahman S; Todd S; Poynton S; Black S; Merinda T; Farrell M, 2024, 'The impact of the NSW MERIT diversion program reoffending, imprisonment, and health', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=7YQqzJTbdAs&t=1808s

Acheson L; Ezard N; Lintzeris N; Dunlop A; Brett J; Rodgers C; Gill A; Christmass M; McKetin R; Farrell M; Shoptaw S; Siefried K, 2022, 'Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot safety and feasibility trial', presented at The 2022 APSAD Scientific Alcohol and Drugs Conference, Darwin, Australia, 09 October 2022 - 12 October 2022, https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.13537

Siefried K; Acheson L; Williams B; Farrell M; McKetin R; Ezard N, 2022, 'OUTCOMES AND MEASURES USED IN RANDOMISED CONTROLLED TRIALS EXAMINING PHARMACOTHERAPIES FOR THE TREATMENT OF METHAMPHETAMINE WITHDRAWAL: RESULTS OF A SYSTEMATIC REVIEW', presented at The College on Problems of Drug Dependence 84th Annual Scientific Meeting, Minneapolis, USA, 11 June 2022 - 15 July 2022, https://d2p55c5k0gw6a2.cloudfront.net/wp-content/uploads/2022/07/2022-CPDD-Abstract-Book.pdf

Siefried K; Arunogiri S; Brett J; McKetin R; Acheson LS; Knock E; Farrell M; Dunlop A; Lintzeris N; Ezard N, 2021, 'The future of pharmacotherapy clinical trials in Australia: the OLAM trial; the MOXY trial; the PSIMA trial; the TINA trial', presented at The APSAD Scientific Drug and Alcohol Conference, Virtual, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384

Larance B; Peacock A; Campbell G; Freckleton S; Smith K; Mattick R; Bruno R; Nielsen S; Cohen M; Lintzeris N; Shand F; Hall WD; Farrell M; Degenhardt L; Peacock A, 2014, 'ALCOHOL USE DISORDERS, RISKY ALCOHOL CONSUMPTION AND ADVERSE EVENTS AMONG CHRONIC NON-CANCER PAIN PATIENTS RECEIVING OPIOID THERAPY'

Campbell G; Mattick R; Bruno R; Larance B; Nielsen S; Cohen M; Lintzeris N; Shand F; Hall WD; Farrell M; Degenhardt L, 2014, 'CHARACTERISTICS OF A NATIONAL SAMPLE OF PEOPLE WITH CHRONIC NON-CANCER PAIN PRESCRIBED PRESCRIPTION OPIOIDS'

Larance B; Nielsen S; Hordern A; Lintzeris N; Burns L; Mattick R; Campbell G; Farrell M; Cohen M; Bruno R; Brown A; Johnson J; Degenhardt L, 2014, 'PHARMACEUTICAL OPIOID USE AND PAIN AMONG PEOPLE WHO INJECT DRUGS: BASELINE FINDINGS FROM A PROSPECTIVE COHORT STUDY'

Nielsen S; Larance B; Lintzeris N; Holliday S; Vanderhaven M; Hordern A; Dunlop A; Haber P; Murnion B; Silsbury C; Johnson J; Demirkol A; Sadler C; Phung N; Burns L; Mattick R; Campbell G; Farrell M; Cohen M; Bruno R; Hardy M; Brown A; Houseman J; Degenhardt L, 2014, 'SEEKING TREATMENT FOR PHARMACEUTICAL OPIOID DEPENDENCE: BASELINE CHARACTERISTICS FROM AN IN-TREATMENT COHORT'

Conference Abstracts

Acheson L; Gordon C; McKetin R; Brett J; Christmass M; Rodgers C; Lintzeris N; Dunlop A; Farrell M; Shoptaw S; Ezard N; Siefried K, 2024, 'OBJECTIVE AND SUBJECTIVE SLEEP DURING LISDEXAMFETAMINE TREATMENT OF ACUTE METHAMPHETAMINE WITHDRAWAL: NEW MEASUREMENT PARADIGM', in Drug and Alcohol Dependence, Elsevier, Vol. 260, pp. 110067, http://dx.doi.org/10.1016/j.drugalcdep.2023.110067

Degenhardt L; Clark B; Macpherson G; Leppan O; Nielsen S; Zahra E; Larance B; Kimber J; Martino-Burke D; Hickman M; Farrell M, 2024, 'T82 Buprenorphine Versus Methadone for the Treatment of Opioid Dependence: A Systematic Review and Meta-Analysis of Randomised and Observational Studies', in Drug and Alcohol Dependence, Elsevier, Vol. 260, pp. 110531, http://dx.doi.org/10.1016/j.drugalcdep.2023.110531

Acheson L; McKetin R; Ezard N; Lintzeris N; Brett J; Rodgers C; Christmass M; Gill A; Farrell M; Dunlop A; Shoptaw S; Siefried K, 2023, 'Participant experiences in a pilot study for methamphetamine withdrawal treatment: Implications for retention', in Drug and Alcohol Review, Wiley, Adelaide, Australia, Vol. 42, presented at The Australasian Professional Society on Alcohol and other Drugs Annual Scientific Conference, Adelaide, Australia, 12 November 2023 - 15 November 2023, http://dx.doi.org/10.1111/dar.13749

Woods A; Conigrave K; Foley C; Asare-Doku W; Shakeshaft A; Farrell M; Doyle M, 2023, 'A systematic review of extended-release pharmacotherapies for substance use disorders in incarcerated populations', in A systematic review of extended-release pharmacotherapies for substance use disorders in incarcerated populations, presented at APSAD 2023 Conference, http://dx.doi.org/10.1111/dar.13749

Asare-Doku W; Peprah P; Santo T; Weatherburn D, 2023, 'Global coverage and retention factors of criminal justice-related drug and alcohol treatment programs among offenders: A systematic review', in Global coverage and retention factors of criminal justice-related drug and alcohol treatment programs among offenders: A systematic review, presented at APSAD 2023 Conference, http://dx.doi.org/10.1111/dar.13749

Acheson LS; Gordon C; Ezard N; Lintzeris N; Dunlop AJ; Brett J; Rodgers C; Gill A; Christmass M; McKetin R; Farrell M; Shoptaw S; Siefried KJ, 2022, 'An exploratory analysis of actigraphy and sleep diaries in a methamphetamine withdrawal clinical trial', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S23 - S24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mills L; Mammen K; Deacon RM; Black E; Montebello M; Bruno R; Dunlop AJ; Ezard N; Shakeshaft A; Farrell M; Holmes J; Reid D; Childs S; Siefried KJ; Lintzeris N, 2022, 'Outcomes for clients in opioid treatment programs who use amphetamine type substances: Results from a retrospective analysis of routinely-collected clinical data', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S96 - S97, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700167&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Colledge-Frisby S; Jones N; Degenhardt L; Farrell M; Kwa J; Padmanathan P; Santo T; Hickman M; Gisev N, 2022, 'Suicide and self-harm among people prescribed opioid agonist treatment in New South Wales: A retrospective data linkage study', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S47 - S48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700083&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Williams BH; Acheson LS; Farrell M; McKetin R; Ezard N; Siefried KJ; Farrell M, 2022, 'PHARMACOLOGICAL TREATMENT FOR METHAMPHETAMINE WITHDRAWAL: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS', in AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, SAGE PUBLICATIONS LTD, Vol. 56, pp. 208 - 209

Howard BC; McRobbie H; Petrie D; Barker D; Mendelsohn C; Anderson J; Borland R; Naughton F; Tutka P; Zwar N; Shakeshaft A; Gartner C; Richmond R; Hall W; Mattick RP; Farrell M; Courtney RJ, 2022, 'Effectiveness, safety and cost-effectiveness of vaporised nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: A study protocol for a randomised controlled trial', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S75 - S76

Farrell M; Shahbazi J; Byrne M; Larance B; Lintzeris N; Nielsen S; Grebely J; Shanahan M; Lancaster K; Dore GJ; Ali R; Dunlop AJ; Rodgers C; Degenhardt L, 2021, 'OVERVIEW AND FINDINGS OF THE COLAB STUDY: AN OPEN-LABEL IMPLEMENTATION STUDY OF SUBLOCADE TREATMENT IN SPECIALIST AND PRIMARY CARE SETTINGS IN AUSTRALIA', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 40, pp. S25 - S25, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200062&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Peacock A; Gisev N; Memedovic S; Larance B; Brown J; Cairns R; Buckley N; Farrell M; Degenhardt L, 2020, 'Opioid use and harms associated with a sustained-release tapentadol formulation: A post-marketing surveillance study', in Drug and Alcohol Dependence, Vol. 206, http://dx.doi.org/10.1016/j.drugalcdep.2019.107697

Black E; Deacon RM; Mills L; Dunlop A; Ezard N; Bruno R; Shakeshaft A; Farrell M; Holmes J; Cretikos MA; Montebello M; Reid D; Childs S; Siefried KJ; Mammen K; Lintzeris N, 2019, 'Characteristics and treatment outcomes of the drug treatment population in New South Wales: Focus on amphetamine type stimulants', in Drug and Alcohol Review, Wiley, Hobart, Australia, Vol. 38, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference, Hobart, Australia, 10 November 2019 - 13 November 2019, http://dx.doi.org/10.1111/dar.12991

Acheson LS; Murray E; Clifford B; Siefried KJ; Matthews GV; Ezard N, 2019, 'Optimising care for people who inject drugs: A retrospective medical record review of staphylococcus aureus bactaraemia treatment', in Drug and Alcohol Review, Wiley, Hobart, Australia, Vol. 38, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference, Hobart, Australia, 10 November 2019 - 13 November 2019, http://dx.doi.org/10.1111/dar.12991

Kelly G; Bruno R; Gibbs D; Karlsson A; Uporova J; Sutherland R; Dietze PM; Salom C; Lenton S; Degenhardt L; Farrell M; Peacock A; Farrell M; Peacock A, 2019, 'RECENT USE OF 'CAPSULES CONTENTS UNKNOWN' AMONG A SAMPLE OF PEOPLE WHO FREQUENTLY USE ECSTASY AND OTHER ILLICIT STIMULANTS IN AUSTRALIA', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S60 - S61

Karlsson A; Gibbs D; Kelly G; Uporova J; Dietze PM; Bruno R; Lenton S; Salom C; Degenhardt L; Farrell M; Peacock A, 2019, 'TRENDS IN METHAMPHETAMINE FORMS AND ROUTES OF ADMINISTRATION AMONG PEOPLE WHO REGULARLY CONSUME DRUGS IN AUSTRALIA', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S59 - S59, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100149&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Farnbach S; Foley C; Sara G; Shakeshaft A; Lappin J; Allan J; Courtney RJ; Farrell M; Dobbins T, 2019, 'WHO IS ACCESSING BOTH MENTAL HEALTH AND DRUG AND ALCOHOL SERVICES? MAPPING THE OVERLAP TO IDENTIFY OPPORTUNITIES FOR IMPROVING SPECIALISED CARE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S45 - S45, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100115&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mammen K; Deacon RM; Holmes J; Dunlop AJ; Bruno R; Ryan A; Gardner L; Shakeshaft A; Farrell M; Phung N; Lintzeris N, 2017, 'THE CLINICAL UTILITY OF THE AUSTRALIAN TREATMENT OUTCOMES PROFILE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 36, pp. 50 - 50, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424000500129&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Larance B; Cama E; Bruno R; Farrell M; Ali R; Lintzeris N; Peacock A; Kihas I; Hordern T; White N; Degenhardt L, 2014, 'PATTERNS OF OPIOID CONSUMPTION IN A COHORT OF PEOPLE WHO TAMPER WITH PHARMACEUTICAL OPIOIDS: BASELINE FINDINGS FROM THE NATIONAL OPIOID MEDICATION ABUSE DETERRENCE (NOMAD) STUDY', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 33, pp. 38 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800111&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Farrell M, 1992, 'Making the science and policy connection', in British Journal of Addiction, Vol. 87, pp. 138 - 139

Reports

Sutherland R; Karlsson A; Uporova J; Palmer L; Tayeb H; Chrzanowska A; Chandrasena U; Price O; Bruno R; Dietze P; Lenton S; Salom C; Radke S; Sumner M; Wilson J; Grigg J; Daly C; Thomas N; Degenhardt L; Farrell M; Peacock A; Lenton S; Daly C, 2025, Australia Drug Trends 2025: Key Findings from the National Ecstasy and Related Drugs Reporting System (EDRS) Interviews, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/unsworks/31587, https://www.unsw.edu.au/research/ndarc/resources/australian-drug-trends-2025-key-findings-from-the-edrs

Sutherland R; Karlsson A; Uporova J; Chrzanowska A; Palmer L; Price O; Bruno R; Dietze P; Lenton S; Salom C; Radke S; Curran J; Vella-Horne D; Wilson J; Daly C; Thomas N; Degenhardt L; Farrell M; Peacock A; Palmer L; Price O, 2025, Australian Drug Trends 2025: Key Findings from the National Illicit Drug Reporting System (IDRS) Interviews, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/unsworks/31585, https://www.unsw.edu.au/research/ndarc/resources/australian-drug-trends-2025-key-findings-from-the-idrs

Sutherland R; Karlsson A; Uporova J; Palmer L; Tayeb H; Chrzanowska A; Chandrasena U; Price O; Bruno R; Dietze P; Lenton S; Salom C; Radke S; Sumner M; Wilson J; Grigg J; Daly C; Thomas N; Degenhardt L; Farrell M; Peacock A; Radke S, 2025, Ecstasy And Related Drugs Reporting System (EDRS) Interviews 2025: Background And Methods, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/unsworks/31586, https://www.unsw.edu.au/research/ndarc/resources/australian-drug-trends-2025-key-findings-from-the-edrs

Sutherland R; Karlsson A; Palmer L; Tayeb H; Chrzanowska A; Chandrasena U; Price O; Bruno R; Dietze P; Lenton S; Salom C; Radke S; Curran J; Vella-Horne D; Wilson J; Daly C; Thomas N; Degenhardt L; Farrell M; Peacock A, 2025, Illicit Drug Reporting System (IDRS) Interviews 2025: Background and Methods, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/unsworks/31588, https://www.unsw.edu.au/research/ndarc/resources/australian-drug-trends-2025-key-findings-from-the-idrs

Sutherland R; Chandrasena U; Karlsson A; Uporova J; Tayeb H; Price O; Salom C; Bruno R; Dietze P; Lenton S; Daly C; Thomas N; Radke S; Lloyd Z; Grigg J; Haywood S; Degenhardt L; Farrell M; Peacock A; Haywood S, 2024, Australian Drug Trends 2024: Key Findings From the National Ecstasy and Related Drugs Reporting System (EDRS) Interview, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/unsworks/30462, https://www.unsw.edu.au/research/ndarc/resources/australian-drug-trends-2024-key-findings-from-the-edrs

Sutherland R; Karlsson A; Uporova J; Chandrasena U; Tayeb H; Price O; Bruno R; Dietze P; Lenton S; Salom C; Radke S; Vella-Horne D; Haywood S; Daly C; Thomas N; Degenhardt L; Farrell M; Peacock A; Salom C; Radke S; Farrell M, 2024, Australian Drug Trends 2024: Key Findings from the National Illicit Drug Reporting System (IDRS) Interviews, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/unsworks/30464, https://www.unsw.edu.au/research/ndarc/resources/australian-drug-trends-2024-key-findings-from-the-idrs

Sutherland R; Chandrasena U; Karlsson A; Uporova J; Tayeb H; Price O; Salom C; Bruno R; Dietze P; Lenton S; Daly C; Thomas N; Radke S; Lloyd Z; Grigg J; Haywood S; Degenhardt L; Farrell M; Peacock A, 2024, Ecstasy And Related Drugs Reporting System (EDRS) Interviews 2024: Background And Methods, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/unsworks/30463, https://www.unsw.edu.au/research/ndarc/resources/australian-drug-trends-2024-key-findings-from-the-edrs

Sutherland R; Karlsson A; Uporova J; Chandrasena U; Tayeb H; Price O; Bruno R; Dietze P; Lenton S; Salom C; Radke S; Vella-Horne D; Haywood S; Daly C; Thomas N; Degenhardt L; Farrell M; Peacock A; Tayeb H, 2024, Illicit Drug Reporting System (IDRS) Interviews 2024: Background and Methods, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/unsworks/30465, https://www.unsw.edu.au/research/ndarc/resources/australian-drug-trends-2024-key-findings-from-the-idrs

Asare-Doku W; Stolk S; Peacock AMY; Shakeshaft A; Waller E; Nathan S; Economidis G; Ravulo J; Meo-Sewabu L; D'Este C; Thapa P; Abbott T; Satour T; Tulele L; Wilson K; Doran C; Mhey-Rivas T; Macpherson G; Lynch M; Taylor S; Santo T; Graham D; Baillie G; Tran A; Aiken A; Harwood E; Turner A; Reeve R; Degenhardt L; Farrell M, 2023, Monitoring and Evaluation of the Kava Pilot Program, National Drug and Alcohol Research Centre, UNSW, Sydney, https://www.odc.gov.au/resources/publications/monitoring-and-evaluation-kava-pilot-program

Sutherland R; Karlsson A; King C; Uporova J; Chandrasena U; Jones F; Gibbs D; Price O; Dietze P; Lenton S; Salom C; Bruno R; Wilson J; Grigg J; Daly C; Thomas N; Radke S; Stafford L; Degenhardt L; Farrell M; Peacock A, 2023, Australian Drug Trends 2023: Key Findings from the National Ecstasy and Related Drugs Reporting System (EDRS) Interviews., NDARC, Sydney, http://dx.doi.org/10.26190/1qta-pe36, https://ndarc.med.unsw.edu.au/resource/australian-drug-trends-2023-key-findings-national-ecstasy-and-related-drugs-reporting

Sutherland R; Uporova J; King C; Chandrasena U; Karlsson A; Jones F; Gibbs D; Price O; Dietze P; Lenton S; Salom C; Bruno R; Wilson J; Agramunt S; Daly C; Thomas N; Radke S; Stafford L; Degenhardt L; Farrell M; Peacock A, 2023, Australian Drug Trends 2023: Key Findings from the National Illicit Drug Reporting System (IDRS) Interviews., NDARC, Sydney, http://dx.doi.org/10.26190/1tj1-8454, https://ndarc.med.unsw.edu.au/resource/australian-drug-trends-2023-key-findings-national-illicit-drug-reporting-system-idrs

Shahbazi J; Farrell M; Byrne J; Ali R; Puszka B; Lim XQ; Cook J; Weiss R; Rodgers C; Dunlop A; Lintzeris N; Nielsen S; Grebely J; Zahra E; Degenhardt L; Byrne M, 2023, Considerations for delivering extended-release buprenorphine for opioid dependence in Australia: Preliminary lessons from the Community Long-Acting Buprenorphine (CoLAB) trial, NATIONAL DRUG AND ALCOHOL RESEARCH CENTRE, UNIVERSITY OF NEW SOUTH WALES, SYDNEY, 2020, RANDWICK, 355, http://dx.doi.org/10.26190/zemp-dx93

Chidwick K; Bharat C; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Real-world dosing intervals of long-acting buprenorphine for opioid agonist treatment., UNSW Sydney, Sydney, 345, http://dx.doi.org/10.26190/ayet-f348, https://ndarc.med.unsw.edu.au/resource/real-world-dosing-intervals-long-acting-buprenorphine-opioid-agonist-treatment

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in New South Wales, 2013-2022, UNSW Sydney, Sydney, 347, http://dx.doi.org/10.26190/rzmn-a864, https://ndarc.med.unsw.edu.au/resource/nsw-trends-use-opioid-agonist-treatment-australia-2013-2022

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Queensland, 2013-2022, UNSW Sydney, Sydney, 349, http://dx.doi.org/10.26190/ybm1-3f83, https://ndarc.med.unsw.edu.au/resource/qld-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in South Australia, 2013-2022, UNSW Sydney, Sydney, 350, http://dx.doi.org/10.26190/y21d-yd24, https://ndarc.med.unsw.edu.au/resource/sa-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Tasmania, 2013-2022, UNSW Sydney; National Drug and Alcohol Research Centre, Sydney, 351, http://dx.doi.org/10.26190/q6zj-fx75, https://ndarc.med.unsw.edu.au/resource/tas-trends-use-opioid-agonist-treatment-australia-2013-2022

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in the Australian Capital Territory, 2013-2022, UNSW Sydney; NDARC, Sydney, 346, http://dx.doi.org/10.26190/16m9-6z16, https://ndarc.med.unsw.edu.au/resource/ndarc-technical-reports-345-353

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in the Northern Territory, 2013-2022, UNSW Sydney, Sydney, 348, http://dx.doi.org/10.26190/mt8r-kd57, https://ndarc.med.unsw.edu.au/resource/nt-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Victoria, 2013-2022, UNSW Sydney; National Drug and Alcohol Research Centre, Sydney, 352, http://dx.doi.org/10.26190/gjpp-py45, https://ndarc.med.unsw.edu.au/resource/vic-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Western Australia, 2013-2022, UNSW Sydney; National Drug and Alcohol Research Centre, Sydney, 353, http://dx.doi.org/10.26190/ftbz-w461, https://ndarc.med.unsw.edu.au/resource/wa-trends-use-opioid-agonist-treatment-australia-2013-2022

Back to profile page